These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6134252)

  • 1. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T; Cookson J
    Neuropharmacology; 1983 Apr; 22(4):539-41. PubMed ID: 6134252
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma prolactin and growth hormone levels in manic patients treated with pimozide.
    Cookson JC; Silverstone T; Rees L
    Br J Psychiatry; 1982 Mar; 140():274-9. PubMed ID: 7093595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-partum mania, dopamine, and estrogens.
    Cookson JC
    Lancet; 1982 Sep; 2(8299):672. PubMed ID: 6125807
    [No Abstract]   [Full Text] [Related]  

  • 4. Etiopathogenesis and treatment of psychosis.
    Crow TJ; Harrington CA
    Annu Rev Med; 1994; 45():219-34. PubMed ID: 7911014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Jones BD; Annable L
    Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE; McElroy SL; Strakowski SM; Soutullo CA
    J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 10. [Olanzapine].
    Wittköpper K; El-Armouche A; Eschenhagen T
    Dtsch Med Wochenschr; 2008 Sep; 133(39):1958-62. PubMed ID: 18798132
    [No Abstract]   [Full Text] [Related]  

  • 11. Variability of response to neuroleptics in schizophrenia: clinical, pharmacologic, and neuroendocrine correlates.
    Gelder M; Kolakowska T
    Compr Psychiatry; 1979; 20(5):397-408. PubMed ID: 39704
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine and schizophrenia: an analysis of the theory.
    Carlton PL; Manowitz P
    Neurosci Biobehav Rev; 1984; 8(1):137-51. PubMed ID: 6145134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced growth hormone and prolactin responses in schizophrenia research.
    Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study.
    Pickar D; Vartanian F; Bunney WE; Maier HP; Gastpar MT; Prakash R; Sethi BB; Lideman R; Belyaev BS; Tsutsulkovskaja MV; Jungkunz G; Nedopil N; Verhoeven W; van Praag H
    Arch Gen Psychiatry; 1982 Mar; 39(3):313-9. PubMed ID: 6121545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical assessment of dopamine receptor blockade.
    Sedvall G; Bjerkenstedt L; Lindström L; Wode-Helgodt B
    Life Sci; 1978 Aug; 23(5):425-9. PubMed ID: 29184
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin response in tardive dyskinesia.
    Wolf ME; Bowie L; Keener S; Mosnaim AD
    Biol Psychiatry; 1982 Apr; 17(4):485-90. PubMed ID: 7082714
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder.
    Palomino A; González-Pinto A; Aldama A; González-Gómez C; Mosquera F; González-García G; Matute C
    Schizophr Res; 2007 Sep; 95(1-3):174-8. PubMed ID: 17630258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.